Brisbane, Australia and Delaware, United States, 8 November 2017: Invion Limited (ASX: IVX) is pleased to provide an Investor Update to the market, following the announcement on 31 August 2017 of a strategic transaction with The Cho Group, and the lodgement on 30 October 2017 of the Company’s Notice of Annual General Meeting.
The attached Investor Update provides information on the Strategic Transaction with The Cho Group to develop and commercialise the New Generation PhotoDynamic Therapy, Photosoft, targeted to the treatment of solid cancers.
Investor Briefing: An Investor Briefing will be held at 2.00pm (Brisbane time) on Monday 13 November. Investors are invited to pre-register for the Briefing. To receive a calendar invite and pin number for fast-track access to the call, please follow this link: